Samantha Semenkow
Stock Analyst at Citigroup
(2.15)
# 2,862
Out of 5,106 analysts
66
Total ratings
42.59%
Success rate
-2.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FOLD Amicus Therapeutics | Downgrades: Neutral | $17 → $15 | $14.21 | +2.08% | 2 | Dec 22, 2025 | |
| SYRE Spyre Therapeutics | Initiates: Buy | $64 | $33.96 | +88.46% | 1 | Dec 17, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $16 → $30 | $17.70 | +69.49% | 2 | Dec 9, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $60 → $100 | $66.76 | +49.79% | 2 | Dec 9, 2025 | |
| NKTR Nektar Therapeutics | Initiates: Buy | $102 | $43.47 | +134.64% | 1 | Nov 26, 2025 | |
| AGIO Agios Pharmaceuticals | Initiates: Buy | $38 | $24.75 | +53.54% | 1 | Nov 26, 2025 | |
| RYTM Rhythm Pharmaceuticals | Initiates: Buy | $136 | $111.66 | +21.80% | 1 | Nov 25, 2025 | |
| ARGX argenx SE | Maintains: Buy | $1,041 → $1,124 | $851.30 | +32.03% | 7 | Nov 17, 2025 | |
| BHVN Biohaven | Maintains: Buy | $28 → $14 | $10.72 | +30.60% | 2 | Nov 13, 2025 | |
| PRME Prime Medicine | Maintains: Neutral | $5 → $4.25 | $3.69 | +15.18% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $26 | $22.52 | +15.45% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $33 | $24.24 | +36.14% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $13.20 | +13.64% | 5 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $5 | $13.95 | -64.16% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $2.29 | +336.68% | 4 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.41 | +183.69% | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.06 | +195.57% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $4.49 | +234.08% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $9.38 | +752.57% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $3.81 | +267.45% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $2.18 | +588.07% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $27.03 | +84.98% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $27.73 | +101.95% | 3 | Aug 9, 2023 |
Amicus Therapeutics
Dec 22, 2025
Downgrades: Neutral
Price Target: $17 → $15
Current: $14.21
Upside: +2.08%
Spyre Therapeutics
Dec 17, 2025
Initiates: Buy
Price Target: $64
Current: $33.96
Upside: +88.46%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $16 → $30
Current: $17.70
Upside: +69.49%
Structure Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $60 → $100
Current: $66.76
Upside: +49.79%
Nektar Therapeutics
Nov 26, 2025
Initiates: Buy
Price Target: $102
Current: $43.47
Upside: +134.64%
Agios Pharmaceuticals
Nov 26, 2025
Initiates: Buy
Price Target: $38
Current: $24.75
Upside: +53.54%
Rhythm Pharmaceuticals
Nov 25, 2025
Initiates: Buy
Price Target: $136
Current: $111.66
Upside: +21.80%
argenx SE
Nov 17, 2025
Maintains: Buy
Price Target: $1,041 → $1,124
Current: $851.30
Upside: +32.03%
Biohaven
Nov 13, 2025
Maintains: Buy
Price Target: $28 → $14
Current: $10.72
Upside: +30.60%
Prime Medicine
Nov 11, 2025
Maintains: Neutral
Price Target: $5 → $4.25
Current: $3.69
Upside: +15.18%
Nov 11, 2025
Maintains: Buy
Price Target: $25 → $26
Current: $22.52
Upside: +15.45%
Nov 7, 2025
Maintains: Buy
Price Target: $31 → $33
Current: $24.24
Upside: +36.14%
Oct 29, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $13.20
Upside: +13.64%
Oct 29, 2025
Downgrades: Sell
Price Target: $5
Current: $13.95
Upside: -64.16%
Aug 14, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $2.29
Upside: +336.68%
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.41
Upside: +183.69%
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $4.06
Upside: +195.57%
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $4.49
Upside: +234.08%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $9.38
Upside: +752.57%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $3.81
Upside: +267.45%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.18
Upside: +588.07%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $27.03
Upside: +84.98%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $27.73
Upside: +101.95%